Progyny director Cheryl Scott granted equity awards

Progyny, Inc. director Cheryl Scott received new equity compensation awards.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Progyny, Inc. director Cheryl Scott received new equity compensation awards. She was granted 5,660 restricted stock units, each representing one share of common stock, and 27,119 stock options with an exercise price of $24.69 per share. Both the RSUs and options vest on the earlier of May 21, 2027 or the day before Progyny’s first annual stockholders’ meeting following the grant, subject to her continued board service. After these awards, she holds 19,772 shares of common stock directly, plus the 27,119 options.

Insider Trade Summary

Grant/Award: 32,779 shares

Grant/Award 2 txns

Insider Scott Cheryl

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	27,119	$0.00	$0.00
Grant/Award	Common Stock	5,660	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 27,119 contracts (Direct); Common Stock — 19,772 shares (Direct)

Footnotes (2)

F1. Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
F2. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

Key Figures

RSUs granted: 5,660 units Options granted: 27,119 options Option exercise price: $24.69 per share +3 more

6 metrics

RSUs granted 5,660 units Restricted stock units granted to Cheryl Scott on May 21, 2026

Options granted 27,119 options Stock Option (Right to Buy) granted on May 21, 2026

Option exercise price $24.69 per share Exercise price for 27,119 stock options

Common shares held 19,772 shares Total common stock directly held after the transaction

Underlying option shares 27,119 shares Common stock underlying the new stock option grant

Vesting date May 21, 2027 Final vesting date for RSUs and options, or earlier pre-meeting date

Key Terms

restricted stock units ("RSUs"), contingent right, Stock Option (Right to Buy), exercise price, +2 more

6 terms

restricted stock units ("RSUs") financial

"Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of Issuer common stock."

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price":"24.6900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual meeting of stockholders financial

"the Issuer's first annual meeting of stockholders following the grant date"

vesting financial

"The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Cheryl Scott receive from Progyny (PGNY)?

Cheryl Scott received equity compensation consisting of 5,660 restricted stock units and 27,119 stock options. Each RSU represents one share of Progyny common stock, and the options give her the right to buy additional shares at a fixed exercise price.

How many Progyny (PGNY) shares and options does Cheryl Scott hold after this Form 4?

After the reported grants, Cheryl Scott holds 19,772 shares of Progyny common stock directly and 27,119 stock options. These holdings reflect her position as a director and are tied to ongoing service-based vesting conditions described in the award terms.

What is the exercise price of Cheryl Scott’s new Progyny (PGNY) stock options?

Cheryl Scott’s newly granted stock options have an exercise price of $24.69 per share. This means she can purchase Progyny common stock at that fixed price once the options vest, provided she continues to meet the service requirements for the award.

When do Cheryl Scott’s Progyny (PGNY) RSUs and options vest?

Both the RSUs and stock options vest on the earlier of May 21, 2027 or the calendar day immediately preceding Progyny’s first annual stockholders’ meeting following the grant. Vesting requires Cheryl Scott’s continued service as a director through the applicable vesting date.

Are Cheryl Scott’s Progyny (PGNY) equity awards open-market purchases?

No. The Form 4 shows these as awards granted for zero cost, not open-market purchases. The transactions are coded as “A” for grants, reflecting compensation-related acquisitions of RSUs and options rather than discretionary buying or selling in the public market.

What type of security underlies Cheryl Scott’s Progyny (PGNY) option grant?

The stock option award covers 27,119 shares of Progyny common stock. Once vested, each option allows Cheryl Scott to buy one share at an exercise price of $24.69, giving her potential future ownership if she chooses to exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/26/2026 - 04:21 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scott Cheryl

(Last)

(First)

(Middle)

C/O PROGYNY, INC.

1359 BROADWAY, 2ND FLOOR

(Street)

NEW YORK

10018

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/21/2026		A		5,660⁽¹⁾	A	$0	19,772	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$24.69	05/21/2026		A		27,119		⁽²⁾	05/20/2036	Common Stock	27,119	$0	27,119	D

Explanation of Responses:

1. Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

2. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

Remarks:

	/s/ Mark Livingston, Attorney-in-Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR